The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region
Open accessAbstract
In some mammalian systems small interfering RNAs (siRNA) targeting homologous sequences in promoter regions of genes induce transcriptional gene silencing (TGS). We have previously reported the induction of TGS by an siRNA (prom-A siRNA) targeting the tandem NF-kappaB-binding motifs within the human immunodeficiency virus, type 1 (HIV-1), promoter region. Here we report that induction of TGS by prom-A siRNA is accompanied by immediate and sustained local recruitment of Argonaute-1 (Ago1), histone deacetylase-1 (HDAC1), and induction of dimethylation of histone 3 at lysine 9 (H3K9me2), processes known to be associated with transcriptional silencing. Elevated levels of H3K9me2 and HDAC1 spread upstream of the target sequence, and elevated H3K9me2 levels also spread downstream into the coding region. Moreover, this siRNA induces an immediate change in DNA accessibility to restriction enzyme digestion in the region of the transcription initiation site of the HIV-1. This change in accessibility is because of the relocation of a nucleosome known to be associated with this region of the integrated pro-virus. Although there is a theoretical possibility that the observed viral suppression could be mediated by the PTGS mechanism with this siRNA acting at the 3 (R)-long term repeat of the virus, we demonstrate that this siRNA, and three other U3 targeted siRNAs, are inefficient inducers of PTGS. These data strongly suggest that siRNA targeting the promoter region acts predominantly at a site within the 5 (R)-long term repeat of HIV to induce transcriptional silencing and alterations to chromatin structure of the HIV promoter region that extend well beyond the immediate siRNA target site. These induced changes are consistent with those described in latent HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The first anti-HIV-1, siPromA, was first identified in 2005 [309], and targeted the unique and highly conserved NK-κB transcription factor sites in the HIV-1 promoter to induce potent epigenetic silencing [70,310,311,312].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [310]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pulukuri, S. M. K., & Rao, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0751 · Cited by 62
RetractedAdachi, A., Gendelman, H. E., Koenig, S., Folks, T. M., Willey, R. L., Rabson, A. B., & Martín, M. Á. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,805
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Role of Histone H3 Lysine 9 Methylation in Epigenetic Control of Heterochromatin Assembly
Nakayama, J.-I., Rice, J. C., Strahl, B. D., Allis, C. D., & Grewal, S. I. S. (2001) · Science · doi:10.1126/science.1060118 · Cited by 1,739
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Genetic and Functional Diversification of Small RNA Pathways in Plants
Xie, Z., Johansen, L. K., Gustafson, A. M., Kasschau, K. D., Lellis, A. D., Zilberman, D., Jacobsen, S. E., & Carrington, J. C. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020104 · Cited by 1,569
Argonaute proteins: key players in RNA silencing
Hutvágner, G., & Simard, M. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2321 · Cited by 1,386
Carrozza, M. J., Li, B., Florens, L. A., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W.-J., Anderson, S., Yates, J. R., Washburn, M. P., et al. (2005) · Cell · doi:10.1016/j.cell.2005.10.023 · Cited by 1,338
P bodies and the control of mRNA translation and degradation
Parker, R., & Sheth, U. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.011 · Cited by 1,335
Flagged first, then by citations
Research works printed but not linked: 2
- Suzuki, 2005, J. RNAi Gene Silencing, 1, 66
- Hutvagner, 2008, Nat. Rev. Mol. Cell Biol., 105, 512
Cited by
Sorted by citations
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Broder, S. E. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.002 · Cited by 521
Delcuve, G. P., Khan, D. H., & Davie, J. R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-5 · Cited by 505
Control of alternative splicing through siRNA-mediated transcriptional gene silencing
Alló, M., Buggiano, V., Fededa, J. P., Petrillo, E., Schor, I., de la Mata, M., Agirre, E., Plass, M., Eyras, E., Elela, S. A., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1620 · Cited by 340
Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells
Hawkins, P. G., Santoso, S., Adams, C., Anest, V., & Morris, K. V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp127 · Cited by 197
Small silencing RNAs: State-of-the-art
Grimm, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.002 · Cited by 190
An HIV-Encoded Antisense Long Noncoding RNA Epigenetically Regulates Viral Transcription
Saayman, S. M., Ackley, A., Turner, A. W., Famiglietti, M., Bosque, A., Clemson, M., Planelles, V., & Morris, K. V. (2014) · Molecular Therapy · doi:10.1038/mt.2014.29 · Cited by 181
Chu, Y., Yue, X., Younger, S. T., Janowski, B. A., & Corey, D. R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq648 · Cited by 173
Block-And-Lock Strategies to Cure HIV Infection
Vansant, G., Bruggemans, A., Janssens, J., & Debyser, Z. (2020) · Viruses · doi:10.3390/v12010084 · Cited by 183
Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy
Perrone, L., Devi, T. S., Hosoya, K.-I., Terasaki, T., & Singh, L. P. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.42 · Cited by 143
Alló, M., Agirre, E., Bessonov, S., Bertucci, P., Acuña, L. I. G., Buggiano, V., Bellora, N., Singh, B., Petrillo, E., Blaustein, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416858111 · Cited by 107
Morris, K. V. (2009) · Epigenetics · doi:10.4161/epi.4.5.9282 · Cited by 100
Chromatin remodeling by the small RNA machinery in mammalian cells
Li, L. (2013) · Epigenetics · doi:10.4161/epi.26830 · Cited by 95
Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy
Sherbet, G. V. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.037 · Cited by 95
Transcriptional gene silencing in humans
Weinberg, M. S., & Morris, K. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw139 · Cited by 95
RNA interference approaches for treatment of HIV-1 infection
Bobbin, M. L., Burnett, J., & Rossi, J. J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0174-y · Cited by 95
Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs.
Malecová, B., & Morris, K. V. (2010) · PubMed · Cited by 92
Absence of DICER in Monocytes and Its Regulation by HIV-1
Coley, W., Duyne, R. V., Carpio, L., Guendel, I., Kehn‐Hall, K., Chevalier, S. A., Narayanan, A., Luu, T. V., Lee, N., Klase, Z. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101709 · Cited by 88
Ahlenstiel, C., Lim, H., Cooper, D. A., Ishida, T., Kelleher, A. D., & Suzuki, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr891 · Cited by 81
Self-citationRetroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription
Yamagishi, M., Ishida, T., Miyake, A., Cooper, D. A., Kelleher, A. D., Suzuki, K., & Watanabe, T. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.02.003 · Cited by 77
Self-citationCai, H., Zhu, X., Ao, J., Ye, B., Zhang, Y.-Y., Chai, Z., Wang, C.-H., Shi, W.-K., Cao, M.-Q., Li, X., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1333213 · Cited by 75
Block and Lock HIV Cure Strategies to Control the Latent Reservoir
Ahlenstiel, C., Symonds, G. P., Kent, S. J., & Kelleher, A. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00424 · Cited by 73
Self-citationThe search for an HIV cure: tackling latent infection
Kent, S. J., Reece, J. C., Petravic, J., Martyushev, A., Kramski, M., Rose, R. D., Cooper, D. A., Kelleher, A. D., Emery, S., Cameron, P. U., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70043-4 · Cited by 71
Self-citationRNA-Directed Transcriptional Gene Silencing and Activation in Human Cells
Morris, K. V. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0212 · Cited by 70
The emerging role of pseudogene expressed non-coding RNAs in cellular functions
Groen, J., Capraro, D., & Morris, K. V. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.008 · Cited by 69
Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
Suzuki, K., Hattori, S., Marks, K., Ahlenstiel, C., Maeda, Y., Ishida, T., Millington, M., Boyd, M., Symonds, G., Cooper, D. A., et al. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.64 · Cited by 61
Self-citationReceptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
Zhou, J., Lazar, D. C., Li, H., Xia, X., Satheesan, S., Charlins, P., O’Meally, D., Akkina, R., Saayman, S. M., Weinberg, M. S., et al. (2018) · Theranostics · doi:10.7150/thno.23085 · Cited by 61
Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing
Ahlenstiel, C., Méndez, C., Lim, S. T. H., Marks, K., Turville, S. G., Cooper, D., Kelleher, A. D., & Suzuki, K. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.31 · Cited by 65
Self-citationChromatin dynamics associated with HIV-1 Tat-activated transcription
Easley, R. L., Duyne, R. V., Coley, W., Guendel, I., Dadgar, S., Kehn‐Hall, K., & Kashanchi, F. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.008 · Cited by 58
Turner, A. W., Cruz, J. D. L., & Morris, K. V. (2008) · Molecular Therapy · doi:10.1038/mt.2008.268 · Cited by 59
Therapeutic targeting of non-coding RNAs
Roberts, T. C., & Wood, M. J. A. (2013) · Essays in Biochemistry · doi:10.1042/bse0540127 · Cited by 59
Coupling Between Transcription and Alternative Splicing
Schor, I. E., Acuña, L. I. G., & Kornblihtt, A. R. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-31659-3_1 · Cited by 57
Cho, S., Park, J. S., & Kang, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku788 · Cited by 55
Controlling Transcription with Noncoding RNAs in Mammalian Cells
Turner, A. W., & Morris, K. V. (2010) · BioTechniques · doi:10.2144/000113442 · Cited by 53
Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific
Suzuki, K., Ishida, T., Yamagishi, M., Ahlenstiel, C., Swaminathan, S., Marks, K., Murray, D. D., McCartney, E. M., Beard, M. R., Alexander, M. R., et al. (2011) · RNA Biology · doi:10.4161/rna.8.6.16264 · Cited by 51
Self-citationRNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
Méndez, C., Ledger, S., Petoumenos, K., Ahlenstiel, C., & Kelleher, A. D. (2018) · Retrovirology · doi:10.1186/s12977-018-0451-0 · Cited by 59
Self-citationMeasuring the Success of HIV-1 Cure Strategies
Thomas, J., Ruggiero, A., Paxton, W. A., & Pollakis, G. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00134 · Cited by 51
Long Non-Coding RNA Targeting and Transcriptional De-Repression
Weinberg, M. S., & Morris, K. V. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0412 · Cited by 44
Mazda, M., Nishi, K., Naito, Y., & Ui‐Tei, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028688 · Cited by 40
Non-coding RNAs, epigenetic memory and the passage of information to progeny
Morris, K. V. (2009) · RNA Biology · doi:10.4161/rna.6.3.8353 · Cited by 39
The emerging role of RNA in the regulation of gene transcription in human cells
Morris, K. V. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.017 · Cited by 38
Characterization of an HIV-Targeted Transcriptional Gene-Silencing RNA in Primary Cells
Turner, A. W., Ackley, A., Matrone, M. A., & Morris, K. V. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.165 · Cited by 37
Bhargavan, B., Woollard, S. M., & Kanmogne, G. D. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.11.005 · Cited by 38
Toscano-Garibay, J. D., & Aquino‐Jarquín, G. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1703 · Cited by 34
Nakano, K., Uchimaru, K., Utsunomiya, A., Yamaguchi, K., & Watanabe, T. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1739 · Cited by 34
Transcription-dependent silencing of inducible convergent transgenes in transgenic mice
Calero‐Nieto, F. J., Bert, A. G., & Cockerill, P. N. (2010) · Epigenetics & Chromatin · doi:10.1186/1756-8935-3-3 · Cited by 32
Singh, A. N., Palanichamy, J. K., Ramalingam, P., Kassab, M., Bhagat, M., Andrabi, R., Luthra, K., Sinha, S., & Chattopadhyay, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt348 · Cited by 31
Small RNA-Mediated Epigenetic Myostatin Silencing
Roberts, T. C., Andaloussi, S. E., Morris, K. V., McClorey, G., & Wood, M. J. A. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.15 · Cited by 28
Suzuki, K., Levert‐Mignon, A., Yeung, J. Y. K., Starr, M., Cameron, J., Williams, R., Rismanto, N., Stark, T., Druery, D., Prasad, S., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003001 · Cited by 28
Self-citationPromoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription
Suzuki, K., Ahlenstiel, C., Marks, K., & Kelleher, A. D. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.67 · Cited by 26
Self-citationNoncoding RNAs and LRRFIP1 Regulate TNF Expression
Shi, L., Li, S., Fitzgerald, M., Maurer, K., Bagashev, A., & Sullivan, K. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302063 · Cited by 25
Literature review of baseline information to support the risk assessment of RNAi‐based GM plants
Pačes, J., Nič, M., Novotny, T., & Svoboda, P. (2017) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2017.en-1246 · Cited by 27
Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure
Ahlenstiel, C., Suzuki, K., Marks, K., Symonds, G. P., & Kelleher, A. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00474 · Cited by 24
Self-citationAckley, A., Lenox, A., Stapleton, K., Knowling, S., Lu, T. T., Sabir, K. S., Vogt, P. K., & Morris, K. V. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.33 · Cited by 23
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Following previous failed attempts, including DNA vaccines that did not prevent later infection due to transient activation, including recombinant vaccinia virus (RVV) and inactivated BLV, the attenuated BLV succeeded with deletions in genes that regulate infectivity and replication [351].”
MethodSelf-citationInnate and Adaptive Factors Regulating Human Immunodeficiency Virus Type 1 Genomic Activation
Shah, S., Nonnemacher, M. R., Pirrone, V., & Wigdahl, B. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9207-x · Cited by 22
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus
Méndez, C. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i3.219 · Cited by 23
Ross, J. P., Suetake, I., Tajima, S., & Molloy, P. L. (2010) · Biochemical Journal · doi:10.1042/bj20100579 · Cited by 22
The Varied Roles of Nuclear Argonaute-Small RNA Complexes and Avenues for Therapy
Ross, J. P., & Kassir, Z. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.54 · Cited by 19
ElHefnawi, M., Hassan, N. M., Kamar, M., Siam, R., Remoli, A. L., El-Azab, I. A., AlAidy, O., Marsili, G., & Sgarbanti, M. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr555 · Cited by 19
Palanichamy, J. K., Mehndiratta, M., Bhagat, M., Ramalingam, P., Das, B., Das, P., Sinha, S., & Chattopadhyay, P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0977 · Cited by 18
Tsukamoto, T. (2018) · AIDS · doi:10.1097/qad.0000000000001882 · Cited by 18
Higaki, K., Hirao, M., Kawana‐Tachikawa, A., Iriguchi, S., Kumagai, A., Ueda, N., Bo, W., Kamibayashi, S., Watanabe, A., Nakauchi, H., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.07.017 · Cited by 18
Self-citationHIV cure strategies: which ones are appropriate for Africa?
Abana, C. Z.-Y., Lamptey, H., Bonney, E. Y., & Kyei, G. B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04421-z · Cited by 16
Zakaria, M. K., Khan, I., Mani, P., Chattopadhyay, P., Sarkar, D. P., & Sinha, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-582 · Cited by 15
HIV Latency and the Noncoding RNA Therapeutic Landscape
Saayman, S. M., Roberts, T. C., Morris, K. V., & Weinberg, M. S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2432-5_9 · Cited by 14
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV
Bowden-Reid, E., Moles, E., Kelleher, A. D., & Ahlenstiel, C. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01788-x · Cited by 15
Self-citationAchieving HIV-1 Control through RNA-Directed Gene Regulation
Klemm, V., Mitchell, J., Cortez‐Jugo, C., Cavalieri, F., Symonds, G. P., Caruso, F., Kelleher, A. D., & Ahlenstiel, C. (2016) · Genes · doi:10.3390/genes7120119 · Cited by 11
Self-citationTranscriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections
Sampey, G. C., Guendel, I., Das, R., Jaworski, E. M., Klase, Z. A., Narayanan, A., Kehn‐Hall, K., & Kashanchi, F. (2012) · Biology · doi:10.3390/biology1020339 · Cited by 11
Small RNA-Induced Transcriptional Gene Regulation in Mammals
Green, V. A., & Weinberg, M. S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-415795-8.00005-2 · Cited by 10
Janssens, J., Kim, P., Kim, S. J., Wedrychowski, A., Kadiyala, G. N., Hunt, P. W., Deeks, S. G., Wong, J. K., & Yukl, S. A. (2024) · JCI Insight · doi:10.1172/jci.insight.183084 · Cited by 8
Stable Transcriptional Repression and Parasitism of HIV-1
Shrivastava, S., Charlins, P., Ackley, A., Embree, H. D., Dropulić, B., Akkina, R., Weinberg, M. S., & Morris, K. V. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.011 · Cited by 8
Knowling, S., Stapleton, K., Turner, A. W., Uhlmann, E., Lehmann, T. J., Vollmer, J., & Morris, K. V. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.8 · Cited by 8
Estrategias de curación de la infección por VIH
Rodríguez-Muñoz, J., & Moreno, S. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.01.007 · Cited by 8
Strategies for the cure of HIV infection
Rodríguez-Muñoz, J., & Moreno, S. (2019) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2019.02.001 · Cited by 7
Tsukamoto, T. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030114 · Cited by 5
Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types
Czuba‐Wojnilowicz, E., Klemm, V., Cortez‐Jugo, C., Turville, S. G., Aggarwal, A., Caruso, F., Kelleher, A. D., & Ahlenstiel, C. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01030 · Cited by 6
Self-citationModulation of gene-specific epigenetic states and transcription by non-coding RNAs
Morris, K. V. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0034-6 · Cited by 6
RNA-directed epigenetic silencing of Periostin inhibits cell motility
Lister, N. C., Clemson, M., & Morris, K. V. (2015) · Royal Society Open Science · doi:10.1098/rsos.140545 · Cited by 5
Bertolotti, R. (2009) · Gene Therapy and Regulation · doi:10.1142/s1568558609000102 · Cited by 5
Lessons from Viral Latency in T Cells: Manipulating HIV-1 Transcription by Sirna
Suzuki, K., & Kelleher, A. D. (2010) · HIV Therapy · doi:10.2217/hiv.10.1 · Cited by 5
Self-citationKassab, M. A., Mudassir, M., Singh, A. N., Muthuraman, N., Bhagat, M., Palanichamy, J. K., Ramalingam, P., Chosdol, K., Sinha, S., & Chattopadhyay, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128416 · Cited by 4
RNA-DIRECTED CONTROL OF TRANSCRIPTION IN HUMAN CELLS: SPECIFICALLY TURNING GENES ON OR OFF
Morris, K. V. (2009) · Gene Therapy and Regulation · doi:10.1142/s1568558609000096 · Cited by 4
Esmaeili, F., Bamdad, T., & Ghasemi, S. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9347-6 · Cited by 4
Mechanisms for Controlling HIV-1 Infection: A Gene Therapy Approach
Ognenovska, K., Klemm, V., Ledger, S., Turville, S. G., Symonds, G. P., Kelleher, A. D., & Ahlenstiel, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79669 · Cited by 3
Self-citationShi, Y., Huang, R., Zhang, Y., Feng, Q., Pan, X., & Wang, L. (2022) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2021.0346 · Cited by 2
Virome-wide analysis of histone modification mimicry motifs carried by viral proteins
Xiao, Y., Yuan, S., Qiu, Y., & Ge, X. (2024) · Virologica Sinica · doi:10.1016/j.virs.2024.09.004 · Cited by 1
Targeted Small Noncoding RNA-Directed Gene Activation in Human Cells
Damski, C., & Morris, K. V. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0931-5_1 · Cited by 1
The Use of Small Noncoding RNAs to Silence Transcription in Human Cells
Morris, K. V. (2011) · Neuromethods · doi:10.1007/978-1-61779-114-7_3 · Cited by 1
(2014) · Microbiology Australia · doi:10.1071/mav35n2 · Cited by 1
Strategies for HIV-1 elimination
Zhang, C., Waight, E. M., & Dash, P. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00019-5 · Cited by 1
RNA duplexes in transcriptional regulation
Swaminathan, S., Hood, C. L., Suzuki, K., & Kelleher, A. D. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.021 · Cited by 1
Self-citationHIV, hepatitis viruses and viral STIs: intertwined fates?
Cunningham, T. (2014) · Microbiology Australia · doi:10.1071/ma14025 · Cited by 1
Structural characterization of the minimal human RISC-loading complex
Schell, S. L. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4408
Promoter targeted small RNAs: stabilising viral reservoirs
Kelleher, A. D. (2014) · Microbiology Australia · doi:10.1071/ma14033
Self-citationBarichievy, S. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Gene Therapy for HIV-1 Infection
Arbuthnot, P. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-410518-8.00008-9
Tsukamoto, T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/190702
Resolving the Sites of HIV Entry: Dynamin Networks Hold the Key
Aggarwal, A., & Turville, S. G. (2017) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000173
Kent, S. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00105-2
RNAi and miRNA pathways in mammals II – biological roles
Svoboda, P. (2020) · Karolinum Press eBooks · doi:10.14712/9788024643724.4
Metadata
- Authors
- Suzuki, K., Juelich, T., Lim, H., Ishida, T., Watanebe, T., Cooper, D. A., Rao, S., & Kelleher, A. D.
- Affiliations
- St Vincent's Hospital Sydney (AU)
- UNSW Sydney (AU)
- The University of Tokyo (JP)
- Corresponding author
- Suzuki, Kazuo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 283
- Issue
- 34
- Pages
- 23353-23363
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2516975
- OpenAlex
- W1993695454
- Cited by
- 108
- References
- 79
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 4 · 2015: 10 · 2014: 12 · 2013: 9 · 2012: 5
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- National Institutes of Health (pNL4-3)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HIV-1 promoter, transcriptional silencing, siRNA, RNA duplex, AGO1, HDAC1, H3K9 dimethylation, chromatin structure, DNA accessibility, long terminal repeat, HIV latency
- MeSH terms
- Binding Sites, Chromatin, HeLa Cells, HIV, Humans, Models, Biological, Nucleosomes, Promoter Regions, Genetic, RNA, Transcription, Genetic, Transfection, HIV-1, NF-kappa B, Gene Silencing, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
